Regeneron to report fourth quarter and full year 2022 financial and operating results and host conference call and webcast on february 3, 2023

Tarrytown, n.y., jan. 03, 2023 (globe newswire) -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced that it will report its fourth quarter and full year 2022 financial and operating results on friday, february 3, 2023, before the u.s. financial markets open. the company will host a conference call and simultaneous webcast at 8:30 am eastern time that day.
REGN Ratings Summary
REGN Quant Ranking